Forssman expression on human erythrocytes: Biochemical and genetic evidence of a new histo-blood group system

Blood

Volumn 121, Issue 8, 2013, Pages 1459-1468

  Svensson, Lola ^a,b   Hult, Annika K ^c,d   Stamps, Robert ^e   Ångström, Jonas ^a   Teneberg, Susann ^a   Storry, Jill R ^c,d   Jørgensen, René ^f   Rydberg, Lennart ^a,b   Henry, Stephen M ^g   Olsson, Martin L ^c,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Lund University   (Sweden)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f STATENS SERUM INSTITUT   (Denmark)

^g AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FORSSMAN ANTIGEN; GBGT1 PROTEIN; GLUTAMINE; SYNTHETASE; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; CELL DESTRUCTION; CONTROLLED STUDY; ENZYME REACTIVATION; ERYTHROCYTE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; INTRAVASCULAR HEMOLYSIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84874402159     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-10-455055     Document Type: Article

References (45)

1. Landsteiner K. Zur Kenntnis der antifermenta-tiven, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zbl Bakt. 1900;27:357-362.
2. Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biologic function. Glycobiology. 1999;9(8):747-755. (Pubitemid 29376001)
3. Reid ME, Lomas-Francis C, Olsson ML. The Blood Group Antigen FactsBook. 3rd Ed. San Diego, CA: Elsevier Academic Press; 2012.
4. Oriol R. Tissular expression of ABH and Lewis antigens in humans and animals: expected value of different animal models in the study of ABO-incompatible organ transplants. Transplant Proc. 1987;19(6):4416-4420. (Pubitemid 18049630)
5. Macher BA, Galili U. The Galalpha1, 3Galbeta1, 4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Bio-phys Acta. 2008;1780(2):75-88.
6. Forssman J. Die Herstellung hochwertiger spezi-fischer Schafhämolysine ohne Verwendung von Schafblut: Ein Beitrag Zur Lehre von heterologer Antikörperbildung. Biochem Zeit. 1911;37:78-115.
7. Haslam DB, Baenziger JU. Expression cloning of Forssman glycolipid synthetase: A novel member of the histo-blood group ABO gene family. Proc Natl Acad Sci U S A. 1996;93(20):10697-10702. (Pubitemid 26333051)
8. Bishop JR, Gagneux P. Evolution of carbohydrate antigens-microbial forces shaping host gly-comes? Glycobiology. 2007;17(5):23R-34R. (Pubitemid 47053737)
9. Moulds JM, Moulds JJ. Blood group associations with parasites, bacteria, and viruses. Transfus Med Rev. 2000;14(4):302-311.
10. Cserti CM, Dzik WH. The ABO blood group system and plasmodium falciparum malaria. Blood. 2007;110(7):2250-2258. (Pubitemid 47523142)
11. Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115(23):4635-4643.
12. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 10th Ed. London, United Kingdom: Blackwell Scientific; 1997.
13. Stamps R, Sokol RJ, Leach M, Herron R, Smith G. A new variant of blood group A: Apae. Transfusion. 1987;27(4):315-318. (Pubitemid 17106172)
14. Svensson L, Bindila L, Angstrom J, et al. The structural basis of blood group A-related glycolip-ids in an A3 red cell phenotype and a potential explanation to a serologic phenomenon. Glycobi-ology. 2011;21(2):162-174.
15. Xu H, Storch T, Yu M, Elliott SP, Haslam DB. Characterization of the human Forssman synthe-tase gene. An evolving association between gly-colipid synthesis and host-microbial interactions. J Biol Chem. 1999;274(41):29390- 29398.
16. Schnaar RL, Needham LK. Thin-layer chromatog-raphy of glycosphingolipids. Methods Enzymol. 1994;230:371-389.
17. Svensson L, Rydberg L, Hellberg A, Gilliver LG, Olsson ML, Henry SM. Novel glycolipid variations revealed by monoclonal antibody immunochemi-cal analysis of weak ABO subgroups of A. Vox Sang. 2005;89(1):27-38. (Pubitemid 40846436)
18. Karlsson H, Halim A, Teneberg S. Differentiation of glycosphingolipid- derived glycan structural iso-mers by liquid chromatography/mass spectrom-etry. Glycobiology. 2010;20(9):1103-1116.
19. Marion D, Wuthrich K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun. 1983;113(3):967-974.
20. Hosseini-Maaf B, Hellberg A, Chester MA, Olsson ML. An extensive PCR-ASP strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup and hybrid alleles. Transfusion. 2007;47(11):2110-2125. (Pubitemid 47623981)
21. Frame T, Carroll T, Korchagina E, Bovin N, Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion. 2007;47(5):876-882. (Pubitemid 46669002)
22. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990;345(6272):229-233.
23. 1gene at the blood group ABO locus. Vox Sang. 1996;70(1):26-30. (Pubitemid 26018133)
24. Ando S, Kon K, Nagai Y, Yamakawa T. Anovel pentaglycosyl ceramide containing di-beta-N-acetylgalactos-aminyl residue (Para-Forssman glycolipid) isolated from human erythrocyte membrane. Adv Exp Med Biol. 1982;152:71-81.
25. Thorn JJ, Levery SB, Salyan ME, et al. Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phe-notype. Biochemistry. 1992;31(28):6509-6517.
26. Clausen H, McKibbin JM, Hakomori S. Monoclonal antibodies defining blood group A variants with difucosyl type 1 chain (ALeb) and difucosyl type 2 chain (ALey). Biochemistry. 1985;24(22):6190-6194. (Pubitemid 16197374)
27. Henry S, Oriol R, Samuelsson B. Lewis histo-blood group system and associated secretory phenotypes. Vox Sang. 1995;69(3):166-182.
28. Turcot-Dubois AL, Le Moullac-Vaidye B, Despiau S, et al. Long-term evolution of the CAZY glycosyltransferase 6 (ABO) gene family from fishes to mammals-a birth-and-death evolution model. Glycobiology. 2007;17(5):516-528. (Pubitemid 47049939)
29. Casals F, Ferrer-Admetlla A, Sikora M, et al. Human pseudogenes of the ABO family show a complex evolutionary dynamics and loss of function. Glycobiology. 2009;19(6):583-591.
30. Patenaude SI, Seto NO, Borisova SN, et al. The structural basis for specificity in human ABO (H) blood group biosynthesis. Nat Struct Biol. 2002;9(9):685-690. (Pubitemid 34977302)
31. Bergsten G, Wullt B, Svanborg C. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol. 2005;295(6-7):487-502. (Pubitemid 41225460)
32. Stromberg N, Marklund BI, Lund B, et al. Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors. EMBO J. 1990;9(6):2001-2010.
33. Tillack TW, Allietta M, Moran RE, Young WW, Jr. Localization of globoside and Forssman glycolip-ids on erythrocyte membranes. Biochim Biophys Acta. 1983;733(1):15-24. (Pubitemid 13044836)
34. Elliott SP, Yu M, Xu H, Haslam DB. Forssman synthetase expression results in diminished shiga toxin susceptibility: a role for glycolipids in determining host-microbe interactions. Infect Immun. 2003;71(11):6543-6552. (Pubitemid 37337714)
35. Lanne B, Olsson BM, Jovall PA, et al. Glycocon-jugate receptors for P-fimbriated Escherichia coli in the mouse: an animal model of urinary tract infection. J Biol Chem. 1995;270(15):9017-9025.
36. Winberg J, Mollby R, Bergstrom J, et al. The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of cynomolgus monkeys. J Exp Med. 1995;182(6):1695-1702.
37. Muthing J, Meisen I, Zhang W, et al. Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology. 2012;22(6):849-862.
38. Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang. 2011;101(1):77-82.
39. Young WW, Jr., Hakomori SI, Levine P. Characterization of anti-Forssman (anti-Fs) antibodies in human sera: their specificity and possible changes in patients with cancer. J Immunol. 1979;123(1):92-96. (Pubitemid 9213551)
40. Schwarting GA, Kundu SK, Marcus DM. Reaction of antibodies that cause paroxysmal cold hemo-globinuria (PCH) with globoside and Forssman glycosphingolipids. Blood. 1979;53(2):186-192. (Pubitemid 9102070)
41. Kawanami J. The appearance of Forssman hapten in human tumor. J Biochem. 1972;72(3):783-785.
42. Hakomori S, Wang SM, Young WW, Jr. Isoanti-genic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A. 1977;74(7):3023-3027. (Pubitemid 8132484)
43. Thuresson B, Chester MA, Storry JR, Olsson ML. ABO Transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allele-specific variations in the 5' and 3'-noncoding regions. Transfusion. 2008;48(3):493-504. (Pubitemid 351294577)
44. Koscielak J. A possible biologic function of carbohydrate structures which are typical of erythrocytes. Med Biol. 1986;64(6):331-334. (Pubitemid 17226775)
45. Varki A. Nothing in glycobiology makes sense, except in the light of evolution. Cell. 2006;126(5):841-845. (Pubitemid 44310787)